Daily Briefing

Weekly review: Is 'Ozempic face' a side effect of the popular weight-loss drug?


Debunking nutrition myths, how to talk about the 'elephant in the room,' and more.

Almost 1 in 4 patients experienced an adverse event while hospitalized (Monday, January 23)

Almost 25% of patients experienced at least one adverse event while in the hospital, according to a new study published in the New England Journal of Medicine—underscoring the continuing need to improve patient safety.

10 nutrition myths, debunked (Tuesday, January 24)

Writing for the New York Times, Sophie Egan surveyed some of the top nutrition experts in the country to identify—and debunk—10 common nutrition myths about fat, plant-based protein, dairy, and more.

5 ways to (finally) talk about the 'elephant in the room' (Wednesday, January 25)

Writing for the Harvard Business Review, Lisa Zigarmi and Julie Diamond outline five steps leaders can take to effectively frame difficult conversations and help their teams address "undiscussables."

'Ozempic face': A side effect of the popular weight-loss drug? (Thursday, January 26)

Demand for popular weight-loss drugs, such as semaglutide and tirzepatide, remains high, but some patients on the drugs are now discovering an unwanted side effect: facial aging, Amy Synnott writes for the New York Times.

6 tips on finding 'lasting satisfaction in life' (Friday, January 27)

While most people "intuitively know that happiness isn't realized from the pursuit of money, status, or fame," they often use these as measures of happiness. Writing for the Harvard Business Review, Ron Carucci, co-founder and managing partner at Navalent, outlines 6 strategies to help you find "lasting satisfaction in life."

 

 

 


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

MORE FROM TODAY'S DAILY BRIEFING

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.